	Improving Radiotherapy Plan Quality for Nasopharyngeal Carcinoma With Enhanced UNet Dose Prediction. Cancer Med Jian J, Yuan X, Xu L, Gong C, Gong X, Zhang Y. PMID: 39953816 [PubMed - indexed for MEDLINE]
	CT features of confirmed nasopharyngeal stenosis in 12 cats. J Feline Med Surg Kang K, Brash R. PMID: 39943866 [PubMed - indexed for MEDLINE]
	Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial. J Hematol Oncol Chen G, Sun DC, Ba Y, Zhang YX, Zhou T, Zhao YY, Zhao HY, Fang WF, Huang Y, Wang Z, Deng C, Hu DS, Wang W, Lin JG, Li GL, Luo SX, Fu ZC, Zhu HS, Wang HL, Cai SL, Kang XQ, Zhang L, Yang YP. PMID: 39920751 [PubMed - indexed for MEDLINE]
	The prognostic value of boost dose in residual cervical lymph nodes in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy: a retrospective study. BMC Cancer Xu M, Wang L, Ding J, Xu Y, Fei Z. PMID: 39920660 [PubMed - indexed for MEDLINE]
	Automated Patient-specific Quality Assurance for Automated Segmentation of Organs at Risk in Nasopharyngeal Carcinoma Radiotherapy. Cancer Control Wang Y, Hu J, Chen L, Zhang D, Zhu J. PMID: 39899269 [PubMed - indexed for MEDLINE]
	Reproduction outcomes and prognostic significance of pregnancy after nasopharyngeal carcinoma treatment. Ann Med Luo M, Liu L, Yang Z, Liang Y, Wen D, Liu S, Li X, Xie C, Tang L, Chen Q, Guo S, Mai H. PMID: 39898604 [PubMed - indexed for MEDLINE]
	Synthetic MRI Combined With Clinicopathological Characteristics for Pretreatment Prediction of Chemoradiotherapy Response in Advanced Nasopharyngeal Carcinoma. Korean J Radiol Chen S, Dai J, Zhao J, Han S, Zhang X, Chang J, Jiang D, Zhang H, Wang P, Hu S. PMID: 39898394 [PubMed - indexed for MEDLINE]
	Multidimensional fatigue and its predictive factors in patients with radiation-induced brain injury after radiotherapy for nasopharyngeal carcinoma: A cross-sectional study. Eur J Oncol Nurs Ye Y, Yang Q, Lu W, So CY, Qiu X, Zhang L. PMID: 39892198 [PubMed - indexed for MEDLINE]
	Epstein-Barr virus-infected nasopharyngeal carcinoma therapeutics: oncoprotein targets and clinical implications. Med Oncol Mark JKK, Teh AH, Yap BK. PMID: 39888474 [PubMed - indexed for MEDLINE]
	Evaluating the influence of anti-PD-1 immunotherapy combined with IMRT on thyroid dysfunction in nasopharyngeal carcinoma. Front Immunol Chen L, Li Z, Li X, Wu S, Gong L, Xu G, Chen S, Zhang Y. PMID: 39885990 [PubMed - indexed for MEDLINE]
	Gemcitabine and cisplatin induction chemotherapy followed by concurrent chemoradiotherapy for stage III-IVA nasopharyngeal carcinoma: A real-world study. Sci Prog Van DN, Viet SN, Phu GH. PMID: 39885780 [PubMed - indexed for MEDLINE]
	Nomogram based on dual-energy computed tomography to predict the response to induction chemotherapy in patients with nasopharyngeal carcinoma: a two-center study. Cancer Imaging Ren H, Huang J, Huang Y, Long B, Zhang M, Zhang J, Li H, Huang T, Liu D, Wang Y, Zhang J. PMID: 39885549 [PubMed - indexed for MEDLINE]
	Clinical significance of post-chemoradiotherapy 2-[(18)F]FDG PET/CT response in locally advanced nasopharyngeal carcinoma: A real-world study. Oral Oncol Mo Y, Wei Y, Liang L, Wu T, Li X, Li R, Fan W, Hu Y, Zhang X. PMID: 39870456 [PubMed - indexed for MEDLINE]
	Deep learning based analysis of G3BP1 protein expression to predict the prognosis of nasopharyngeal carcinoma. PLoS One Zhou L, Yang M, Luo J, Zang H, Fan S, Zhan Y. PMID: 39869565 [PubMed - indexed for MEDLINE]
	A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma. Curr Oncol Spreafico A, Winquist E, Ho C, O'Sullivan B, Bouganim N, Chua N, Doucette S, Siu LL, Hao D. PMID: 39851964 [PubMed - indexed for MEDLINE]
	Immunotherapy combined with chemotherapy without locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: two case reports and a literature review. Front Immunol Gao Y, Shi X, He J, Yao H, Yu G, Zhao L, Ma Y, Zheng H, Zhu M, Zhang C. PMID: 39850881 [PubMed - indexed for MEDLINE]
	Preliminary study on the correlation between thyroid magnetic resonance parameters and radiation dose after radiotherapy for nasopharyngeal carcinoma. Front Public Health Lu K, Zhou C, Ren J, Ni J, Yang W, Wang Y, Jin D, Qian J, Zhu Y, Shi D, Hu W, Xu L. PMID: 39850855 [PubMed - indexed for MEDLINE]
	Efficacy of radiotherapy in treating local recurrence concomitant with distant metastasis of nasopharyngeal carcinoma: a long-term retrospective multicenter study. Clin Exp Metastasis Li L, Deng M, Ren J, Liao W, Zheng L, Ma H, Lang J, Feng M, Luo Y. PMID: 39843651 [PubMed - indexed for MEDLINE]
	Efficacy and safety of molecular targeted therapies in nasopharyngeal carcinoma: a network meta-analysis. BMC Cancer Htet H, Anaghan JRJ, Jaiprakash H, Burud IAS, Subramaniam T, Iezhitsa I, Agarwal R. PMID: 39838362 [PubMed - indexed for MEDLINE]
	Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa. Ann Med Wu KP, Li QQ, Luo XQ, Wang XX, Lai YZ, Tian D, Yang HC, Wei XL, Wang LY, Li QM, Zhu D, Chen SJ, Li YS. PMID: 39834281 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 8429

Page 1 of 422



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy